Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia Moderate”

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07209124
What this trial is testing

Increasing Engagement and Positive Emotional Behavior of Older Adults With Mild-Moderate Dementia With the Use of Motion-Based Technology and Meaningful Activities

Who this might be right for
Dementia
Midwestern University 20
Not applicableStudy completedNCT00467766
What this trial is testing

Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseCaregivers
Pfizer 300
Testing effectiveness (Phase 2)Study completedNCT01466088
What this trial is testing

Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

Who this might be right for
Alzheimer's Disease
Targacept Inc. 386
Post-approval studies (Phase 4)Ended earlyNCT01181921
What this trial is testing

The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Janssen-Cilag, S.A. 1
Not applicableStudy completedNCT03937297
What this trial is testing

A Culturally Appropriate Multimodal Non-pharmacological Intervention for Chinese People With Mild-to-Moderate Dementia

Who this might be right for
Dementia
The University of Hong Kong 216
Large-scale testing (Phase 3)Ended earlyNCT05575076
What this trial is testing

Open-label Extension for Phase 3 Clinical Trials of Simufilam

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 1,081
Testing effectiveness (Phase 2)UnknownNCT04388982
What this trial is testing

The Safety and the Efficacy Evaluation of Allogenic Adipose MSC-Exos in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Ruijin Hospital 9
Testing effectiveness (Phase 2)Study completedNCT01504854
What this trial is testing

Resveratrol for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Alzheimer's Disease Cooperative Study (ADCS) 119
Early research (Phase 1)Study completedNCT01837641
What this trial is testing

LY3002813 in Participants With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 63
Testing effectiveness (Phase 2)Study completedNCT00244322
What this trial is testing

Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 45
Large-scale testing (Phase 3)Ended earlyNCT02327182
What this trial is testing

Safety Study of MT-4666 in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Tanabe Pharma Corporation 117
Early research (Phase 1)Study completedNCT00495417
What this trial is testing

Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Affiris AG 24
Not applicableUnknownNCT04203121
What this trial is testing

The Safety and Scientific Validity of Low-dose Whole Brain Radiotherapy in Alzheimer's Disease.

Who this might be right for
Alzheimer Disease
Kyung Hee University Hospital at Gangdong 10
Not applicableUnknownNCT04828434
What this trial is testing

Virtual Individual Cognitive Stimulation Therapy: a Proof of Concept Study

Who this might be right for
DementiaDementia, VascularDementia, Mixed+8 more
University College, London 34
Testing effectiveness (Phase 2)Study completedNCT00708552
What this trial is testing

Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 576
Testing effectiveness (Phase 2)Study completedNCT03748706
What this trial is testing

PTI-125 for Mild-to-moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer Disease
Pain Therapeutics 13
Testing effectiveness (Phase 2)Study completedNCT00749216
What this trial is testing

Solanezumab Safety Study in Japanese Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 33
Large-scale testing (Phase 3)Ended earlyNCT05026177
What this trial is testing

Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 1,125
Testing effectiveness (Phase 2)Study completedNCT03001557
What this trial is testing

Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia

Who this might be right for
Irregular Sleep-Wake Rhythm Disorder
Eisai Inc. 63
Testing effectiveness (Phase 2)Study completedNCT03867253
What this trial is testing

Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer's Disease
Oryzon Genomics S.A. 24
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation